| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.0M | +5.2% |
| SG&A Expense | $4.1M | -2.8% |
| Operating Income | -$10.1M | -1.8% |
| Income Tax | $0 | — |
| Net Income | -$9.8M | -5.8% |
| EPS (Diluted) | -$3.05 | +2.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $0 | -100.0% |
| Current Assets | $2.6M | -76.7% |
| Total Assets | $4.7M | -64.0% |
| Current Liabilities | $1.8M | +37.3% |
| Total Liabilities | $1.8M | +42.6% |
| Stockholders' Equity | $2.9M | -75.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | -1.7% |
| Investing Cash Flow | $7.8M | +121.5% |
| Financing Cash Flow | $112K | -80.2% |